MedTrace Logo

An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry

NCT02677961 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2026-02-11

No results posted yet for this study

Summary

Translational studies in cancer research can be impeded by the lack of high-quality clinical data that can be correlated with research questions. This is particularly true in the case of rare diseases, such as bone and soft tissue tumors. It is therefore the purpose of this study to create a prospective EHR-based clinical registry for individuals with bone and soft-tissue tumors.

Conditions

  • Neoplasms, Connective and Soft Tissue
  • Bone Neoplasms

Interventions

OTHER

Observation

Sponsors & Collaborators

  • Ohio State University Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • David A Liebner, MD · Ohio State University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-01
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02677961 on ClinicalTrials.gov